GT201500169A - THERAPEUTICALLY ACTIVE DERIVATIVES OF PIRAZOL-PYRIMIDINE - Google Patents
THERAPEUTICALLY ACTIVE DERIVATIVES OF PIRAZOL-PYRIMIDINEInfo
- Publication number
- GT201500169A GT201500169A GT201500169A GT201500169A GT201500169A GT 201500169 A GT201500169 A GT 201500169A GT 201500169 A GT201500169 A GT 201500169A GT 201500169 A GT201500169 A GT 201500169A GT 201500169 A GT201500169 A GT 201500169A
- Authority
- GT
- Guatemala
- Prior art keywords
- pyrimidine
- pirazol
- therapeutically active
- active derivatives
- human
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
UNA SERIE DE DERIVADOS DE PIRAZOL [3,4-D] PIRIMIDINA QUE SON SUSTITUIDOS EN LA POSICIÓN 4 POR UNA FRACCIÓN DIAZA MONOCÍCLICA, BICÍCLICA O ESPIROCÍCLICA, SON BENEFICIOSOS EN EL TRATAMIENTO Y/O PREVENCIÓN DE VARIAS DOLENCIAS HUMANAS, INCLUYENDO DESÓRDENES INFLAMATORIOS, AUTOINMUNES Y ONCOLÓGICOS; ENFERMEDADES VIRALES Y MALARIA; Y RECHAZO DE TRANSPLANTE DE ÓRGANOS Y CÉLULAS.A SERIES OF DERIVATIVES OF PIRAZOLE [3,4-D] PYRIMIDINE WHICH ARE REPLACED IN POSITION 4 BY A MONOCYCLIC, BICYCLIC OR SPIROCYCLIC DIAZA FRACTION, ARE BENEFICIAL IN THE TREATMENT AND / OR PREVENTION OF SEVERAL SELF-INFRINGED HUMAN INJURIES, INCLUDING INFLUENTIOUS HUMAN INCIDENTS AND ONCOLOGICALS; VIRAL DISEASES AND MALARIA; AND REJECTION OF TRANSPLANTATION OF ORGANS AND CELLS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1223021.5A GB201223021D0 (en) | 2012-12-20 | 2012-12-20 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GT201500169A true GT201500169A (en) | 2019-08-30 |
Family
ID=47682284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT201500169A GT201500169A (en) | 2012-12-20 | 2015-06-19 | THERAPEUTICALLY ACTIVE DERIVATIVES OF PIRAZOL-PYRIMIDINE |
Country Status (4)
Country | Link |
---|---|
EC (1) | ECSP15031293A (en) |
GB (1) | GB201223021D0 (en) |
GT (1) | GT201500169A (en) |
MA (1) | MA38279B1 (en) |
-
2012
- 2012-12-20 GB GBGB1223021.5A patent/GB201223021D0/en not_active Ceased
-
2013
- 2013-12-20 MA MA38279A patent/MA38279B1/en unknown
-
2015
- 2015-06-19 GT GT201500169A patent/GT201500169A/en unknown
- 2015-07-20 EC ECIEPI201531293A patent/ECSP15031293A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP15031293A (en) | 2018-07-31 |
MA38279B1 (en) | 2018-10-31 |
MA38279A1 (en) | 2018-02-28 |
GB201223021D0 (en) | 2013-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY36171A (en) | BICYCLIC HETEROAROMATIC DERIVATIVES FUSED AS QUINASE INHIBITORS | |
CR20150379A (en) | DERIVATIVES OF PIRAZOLO-PYRIMIDINE THERAPEUTICALLY ACTIVE | |
ECSP14013224A (en) | SUBSTITUTED RINGED PYRIMIDINES AND USE OF THE SAME | |
PE20151157A1 (en) | SUSTAINED RELEASE RUXOLITINIB DOSAGE FORMS | |
CL2016001629A1 (en) | Tricyclic compounds as anticancer agents | |
CY1119840T1 (en) | CYCLICALLY SUBSTITUTED SOURCES AND USE OF THESE | |
CO7081142A2 (en) | Methods of treating retinal degeneration diseases | |
CU23874B1 (en) | 4-ARIL-1,4-DIHIDRO-1,6-SUBSTITUTED NAFTIRIDINAMIDS AND THEIR USE | |
BR112012016866A2 (en) | Thiazolo [5,4-d] pyrimidines and their use as agrochemicals. | |
ECSP12011692A (en) | DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS | |
CL2014002342A1 (en) | Combined antibody therapy against human csf-1r and its uses. | |
BR112012020863A2 (en) | rifaximin forms and uses thereof | |
ECSP12011716A (en) | (HETEROARILMETIL) SUBSTITUTED THIOHYDANTOINS AS ANTI-CANCER DRUGS | |
CR20160454A (en) | CHROMENE AND 1.1 a, 2.7b — TETRAHYDROCICLOPROPA [C] CHROME PIRIDOPIRAZINADIONAS NOVEDOSAS | |
PE20142457A1 (en) | HETEROCICLIC COMPOUNDS AND THEIR USES | |
EP2601967A4 (en) | Drug and method for the prophylaxis of hiv infection and for the prophylaxis and treatment of diseases caused by or associated with hiv, including aids | |
BR112016029632A2 (en) | fused bicyclic heteroaromatic derivatives as kinase inhibitors | |
CL2017001454A1 (en) | Methods for preparing compositions containing alkaloids and uses thereof | |
GT201500169A (en) | THERAPEUTICALLY ACTIVE DERIVATIVES OF PIRAZOL-PYRIMIDINE | |
PE20150869A1 (en) | TRIS- (HETERO) ARIL-PIRAZOLES AND ITS USE | |
WO2014025749A3 (en) | Small molecule inhibitors of viral protein interactions with human t-rna | |
AR125919A2 (en) | SUSTAINED-RELEASE RUXOLITINIB DOSAGE FORMS | |
ECSP15025357A (en) | SUSTAINED RELEASE RUXOLITINIB DOSAGE FORMS | |
UA114825C2 (en) | Therapeutically active pyrazolo-pyrimidine derivatives | |
CR20120083A (en) | DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS |